Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: What causes the diversity? [4]

Dermatology

Volumn 215, Issue 1, 2007, Pages 86-88

  Dainichi, Teruki ^a   Uchi, Hiroshi ^a   Moroi, Yoichi ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Allopurinol; Drug induced hypersensitivity syndrome; Human leukocyte antigen; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL;

ADULT; AGED; ALLELE; CASE REPORT; DIAGNOSTIC VALUE; DNA FINGERPRINTING; DRUG HYPERSENSITIVITY; FEVER; HLA SYSTEM; HUMAN; LETTER; MACULOPAPULAR RASH; MALE; PATHOGENESIS; PRIORITY JOURNAL; RASH; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

AGED; AGED, 80 AND OVER; ALLELES; ALLOPURINOL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EPIDERMAL NECROLYSIS, TOXIC; FOLLOW-UP STUDIES; GOUT; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SAMPLING STUDIES; STEVENS-JOHNSON SYNDROME; SYNDROME;

EID: 34250888038     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102045     Document Type: Letter

References (11)

1. Shear NH, Knowles SR, Sullivan JR, Shapiro L: Cutaneous reactions to drugs; in Freedberg IM, Eisen AZ, Wolff K, et al (eds): Fitzpatrick's Dermatology in General Medicine, ed 6. New York, McGraw-Hill, 2003, vol 1, pp 1330-1337.
2. Hashimoto K, Yasukawa M, Tohyama M: Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003;3:255-260.
3. Kano Y, Inaoka M, Sakuma K, Shiohara T: Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology 2005;209:165-167.
4. Marsh SG, Albert ED, Bodmer WF, et al: Nomenclature for factors of the HLA system, 2004. Tissue Antigens 2005;65:301-369.
5. Tokunaga K, Ishikawa Y, Ogawa A, et al: Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997;46:199-205.
6. Tanaka H, Akaza T, Juji T: Report of the Japanese Central Bone Marrow Data Center. Clin Transpl 1996:139-144.
7. Hung SI, Chung WH, Liou LB, et al: HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005;102:4134-4139.
8. Lonjou C, Sekula P, Ledger N, et al: A European genetic study of Stevens-Johnson and toxic epidermal necrolysis: HLA-B association with specific high-risk drugs. J Invest Dermatol 2006;126(suppl 3):s37.
9. Chung WH, Hung SI, Hong HS, et al: Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428:486.
10. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-96.
11. Tas S, Simonart T: Herpesviruses in patients with drug hypersensitivity syndrome: culprits, cofactors or innocent bystanders? Dermatology 2006;213:273-276.